JMIR multicenter study (News-Medical 18 Sep): ML using first-14-week data across more than half a million pregnancies in Sweden, Chile, and Singapore generally beat existing early risk tools.
Retrospective risk tool — not a bedside RCT; not Nature Medicine prospective-evidence comment.
News-Medical